Financial Ratios

SHREEKRISHNA BIOTECH LTD.

NSE : NABSE : 505592ISIN CODE : INE571N01015Industry : Finance - InvestmentHouse : Private
BSE141.400 (0 %)
PREV CLOSE ( ) 141.40
OPEN PRICE ( ) 141.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 141.40 (10799)
VOLUME 1
TODAY'S LOW / HIGH ( )141.40 141.40
52 WK LOW / HIGH ( ) 141.4141.4
NSE
This Company is not listed in NSE
Select year
ParticularsMar2013Mar2012Mar2011Mar2010Mar2009
Operational & Financial Ratios
   Earnings Per Share (Rs)0.020.020.000.000.00
   CEPS(Rs)0.030.020.010.010.02
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)12.1312.1112.0811.9911.98
   Tax Rate(%)30.0013.2434.0033.9933.99
Margin Ratios
   Core EBITDA Margin(%)18.0117.83
   EBIT Margin(%)8.406.02
   Pre Tax Margin(%)8.406.02
   PAT Margin (%)5.543.97
   Cash Profit Margin (%)15.1615.79
Performance Ratios
   ROA(%)0.160.130.040.040.04
   ROE(%)0.170.140.040.040.04
   ROCE(%)0.240.160.060.060.06
   Asset Turnover(x)0.000.000.000.010.01
   Sales/Fixed Asset(x)0.000.000.000.110.15
   Working Capital/Sales(x)0.000.000.000.010.01
Efficiency Ratios
   Fixed Capital/Sales(x)9.146.89
   Receivable days4281.923230.34
   Inventory Days106.7680.54
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)107.5581.25
   EV/Core EBITDA(x)284.02356.17596.20597.05455.59
   EV/EBIT(x)329.66499.681278.621280.441349.79
   EV/CE(x)0.750.750.750.750.75
   M Cap / Sales0.000.00
Growth Ratio
   Net Sales Growth(%)-100.00-24.560.00
   Core EBITDA Growth(%)25.0067.390.00-23.800.00
   EBIT Growth(%)51.09155.890.005.270.00
   PAT Growth(%)21.91236.34-0.015.270.00
   EPS Growth(%)22.16236.34-0.015.270.00
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)17.6017.7017.2916.8516.83
   Quick Ratio(x)17.6017.7017.2916.8216.80
   Interest Cover(x)
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.